DHR — DANAHER CORP /DE/
—
NYSE ·
Unknown ·
Unknown ·
CIK 313616 ·
Last close
$225.77
Market Cap
$158.71B
52W High
$241.35
52W Low
$160.31
ADV30
4,137,088
Next earnings
2027-01-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 6,554,000,000 | 3,837,000,000 | 1,245,000,000 | 1,235,000,000 | 93,281,000,000 | 5,682,000,000 | 39,648,000,000 |
| Jun 2026 | 6,265,000,000 | 3,611,000,000 | 1,127,000,000 | 870,000,000 | 92,367,000,000 | 4,348,000,000 | 39,775,000,000 |
| Mar 2026 | 5,951,000,000 | 3,591,000,000 | 1,344,000,000 | 1,029,000,000 | 83,544,000,000 | 5,701,000,000 | 30,587,000,000 |
| Dec 2025 | 6,838,000,000 | 3,966,000,000 | 1,502,000,000 | 1,197,000,000 | 83,464,000,000 | 4,615,000,000 | 30,923,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$6,635,000,000
Investing CF
$-11,092,000,000
Financing CF
$5,860,000,000
CapEx
$-1,169,000,000
Dividends Paid
$-964,000,000
Buybacks
$-2,904,000,000
EPS Diluted TTM
$5.63
As of
2026-10-25
Balance + Analyst (yfinance extras)
Retained Earnings
$48,226,000,000
Inventory
$3,260,000,000
Receivables
$3,965,000,000
ST Investments
—
EBIT TTM
$5,054,000,000
Pretax Income TTM
$4,762,000,000
Interest Exp TTM
$292,000,000
Analysts
21
Yahoo Snapshot (yfinance, live)
Total Revenue
$25,607,999,488
EBITDA
$8,256,000,000
Free Cash Flow
$4,746,250,240
Enterprise Value
$184,275,845,120
Total Cash
$5,681,999,872
Total Debt
$27,782,000,640
Shares Out
702,986,054
Trailing EPS
$6.04
Book Value
$76.23
ROE
8.2%
ROA
4.1%
Div Yield
0.69%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 24,568,000,000 | 4,690,000,000 | 3,614,000,000 | 83,464,000,000 | 30,923,000,000 | 52,534,000,000 | 6,416,000,000 |
| Dec 2024 | 23,875,000,000 | 4,863,000,000 | 3,899,000,000 | 77,542,000,000 | 27,992,000,000 | 49,543,000,000 | 6,688,000,000 |
| Dec 2023 | 23,890,000,000 | 5,202,000,000 | 4,764,000,000 | 84,488,000,000 | 30,998,000,000 | 53,486,000,000 | 7,164,000,000 |
| Dec 2022 | 26,643,000,000 | 7,536,000,000 | 7,209,000,000 | 84,350,000,000 | 34,260,000,000 | 50,082,000,000 | 8,519,000,000 |
TTM Snapshot
Revenues TTM
$25,107,000,000
NetIncome TTM
$4,004,000,000
OpCashFlow TTM
—
Assets (Latest)
$92,367,000,000
Forward EPS
$9.31
Max Pain — expiry 2026-11-27 (volume-derived — Yahoo OI feed degraded)
max pain strike: $225.00 · spot: $228.58 · call volume: 520 · put volume: 283Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LMT | LOCKHEED MARTIN CORP | $136.37B | $590.34 | — |
| KLAC | KLA CORP | $188.36B | $144.56 | — |
| SPOT | Spotify Technology S.A. | $123.76B | $602.01 | — |
| SMERY | Siemens Energy AG/ADR | $118.10B | $27.76 | — |
| IBM | INTERNATIONAL BUSINESS MACHINES CORP | $218.41B | $231.09 | — |
News headlines (Yahoo Finance, 1h cache)
FDA clears Masimo’s brain function monitor
2026-11-19 09:31 · Yahoo
Danaher Targets Faster Growth With Acquisitions, AI and a Diagnostics Push
2026-11-18 08:12 · Yahoo
Global Point of Care (POC) Immunoassay Analyzer Expansion Market 2026 | Capture 8.8% CAGR to 2030 as Roche, Abbott, Siemens Healthineers and Danaher Scale AI-Enabled POC Testing
2026-11-16 15:27 · Yahoo
Danaher (DHR) Is A Key Supplier In Fast Growing Bioprocessing Markets
2026-11-12 19:09 · Yahoo
A Memo To Danaher's Biotechnology Team About Turning Orders Into Sales
2026-11-12 15:13 · Yahoo
Microfluidic Device Systems - Global Strategic Business Report 2026: Capitalize on 8.7% CAGR to $11.1 Billion by 2032 | Abbott, Danaher, Bio-Rad, and Siemens Healthineers Shape the Competition
2026-11-12 14:57 · Yahoo
Tangential Flow Filtration - Global Strategic Business Report 2026: Capitalize on a $2B Revenue Shift to $3.6B by 2032 as Danaher, MilliporeSigma, GE Healthcare, and Alfa Laval Accelerate Competition
2026-11-12 14:56 · Yahoo
Single-Use Bioprocessing - Global Strategic Business Report 2026: Capitalize on 13.4% CAGR to $47.7B by 2032, Featuring Profiles of Danaher, Thermo Fisher Scientific, 3M, and Eppendorf
2026-11-12 14:54 · Yahoo
Danaher’s Cepheid business to lay off 67 people in California
2026-11-11 15:57 · Yahoo
Global Biotechnology Market to Reach $5 Trillion by 2032, Driven by Biopharmaceuticals, Gene Editing and Sustainable Innovation | Features Profiles of Danaher, Roche, Illumina, Merck, Thermo Fisher an
2026-11-11 14:44 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.